These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6105787)

  • 1. Receptor plasticity: biochemical correlates and pharmacological significance.
    Costa E
    Adv Biochem Psychopharmacol; 1980; 24():363-77. PubMed ID: 6105787
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors.
    Roth RH
    Commun Psychopharmacol; 1979; 3(6):429-45. PubMed ID: 44693
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-schizophrenic drugs--membrane receptor sites of action.
    Seeman P
    Biochem Pharmacol; 1977 Oct; 26(19):1741-8. PubMed ID: 20896
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary investigation of a process of desensitization on mammalian presynaptic gamma-aminobutyric (GABA) receptors [proceedings].
    Deschenes M; Feltz P; Rouzaire-Dubois B; Kelly JS
    Br J Pharmacol; 1977 Mar; 59(3):487P. PubMed ID: 843725
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug effects on pre- and postsynaptic dopamine receptors.
    Andén NE; Grabowska-Andén M
    Adv Biochem Psychopharmacol; 1980; 24():57-64. PubMed ID: 6105802
    [No Abstract]   [Full Text] [Related]  

  • 6. Theoretical implications of tolerance development in DA, ACh and GABA turnover after neuroleptic chronic treatment.
    Agnati LF; Zini I; Lenzi P; Cortelli P; Battistini N; Bernardi P
    Boll Soc Ital Biol Sper; 1981 Jun; 57(11):1261-6. PubMed ID: 6116494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects.
    Svartengren J; Pettersson E; Björk A
    Biol Psychiatry; 1997 Aug; 42(4):247-59. PubMed ID: 9270901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptors and antipsychotic drug response.
    Sunahara RK; Seeman P; Van Tol HH; Niznik HB
    Br J Psychiatry Suppl; 1993 Dec; (22):31-8. PubMed ID: 7906523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre- and postsynaptic mechanisms in haloperidol-induced sensitization to dopaminergic agonists.
    Muller P; Svensson TH; Carlsson A
    Adv Biochem Psychopharmacol; 1980; 24():69-74. PubMed ID: 6105807
    [No Abstract]   [Full Text] [Related]  

  • 10. gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia.
    Van Kammen DP
    Am J Psychiatry; 1977 Feb; 134(2):138-43. PubMed ID: 835733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
    [No Abstract]   [Full Text] [Related]  

  • 12. [What is the connection between Parkinson disease and tardive dyskinesia?].
    Gunne LM; Andrén PE
    Lakartidningen; 1994 Aug; 91(34):2953-5. PubMed ID: 7990538
    [No Abstract]   [Full Text] [Related]  

  • 13. Antipsychotic drug action: clinical, biochemical, and pharmacological evidence for site specificity of action.
    Borison RL; Hitri A; Blowers AJ; Diamond BI
    Clin Neuropharmacol; 1983 Jun; 6(2):137-50. PubMed ID: 6133618
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic/dopamine receptors: elevation and reversal.
    List S; Seeman P
    Adv Biochem Psychopharmacol; 1980; 24():95-101. PubMed ID: 6105811
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects.
    Strange PG
    Pharmacol Rev; 2001 Mar; 53(1):119-33. PubMed ID: 11171942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible role for nucleoside-protein complexes in membrane.
    Smythies JR
    Br J Pharmacol; 1971 Feb; 41(2):419P-421P. PubMed ID: 4324597
    [No Abstract]   [Full Text] [Related]  

  • 17. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of relation between dopaminergic and gabaergic mechanisms in chick retina.
    Nistico G; De Sarro A; Urna G; Pujia A; Ientile R
    Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):29-39. PubMed ID: 6135247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of action of the benzodiazepines. New biological data].
    Boulenger JP
    Nouv Presse Med; 1979 Jul; 8(31):2513-8. PubMed ID: 226933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.